Login / Signup

Metformin-Induced Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition Further Decreases Low-Density Lipoprotein Cholesterol Following Statin Treatment in Patients With Coronary Artery Disease and Without Diabetes.

Die HuDonglu QinJie KuangYang YangShuwei WengJin ChenSha WuShuai WangLing MaoDaoquang PengBilian Yu
Published in: Journal of cardiovascular pharmacology (2024)
Chinese Clinical Trial Registry identifier: ChiCTR1900026925 (26/10/2019).
Keyphrases
  • clinical trial
  • cardiovascular disease
  • low density lipoprotein
  • type diabetes
  • high glucose
  • diabetic rats
  • coronary artery disease
  • study protocol
  • phase ii
  • adipose tissue
  • replacement therapy
  • phase iii
  • stress induced